期刊文献+

冠心病介入治疗的临床研究进展 被引量:6

下载PDF
导出
摘要 冠心病介入治疗已有32年历史.世界上第一例经皮腔内冠状动脉成形术(简称PTCA)于1977年由德国医生Gruentzig完成,从此开辟了冠心病经皮介入治疗的新纪元;而1987年Sigwart首先将冠状动脉支架植入术应用于临床,是冠心病治疗的第二个里程碑.中国的第一例PTCA完成于1984年,与世界第一例相比整整晚了7年,但是在此以后,从第一例PTCA到第一例支架置入,再到药物洗脱支架的应用,时间的差距逐步缩小.
作者 米翔
出处 《微创医学》 2011年第5期437-439,共3页 Journal of Minimally Invasive Medicine
  • 相关文献

参考文献18

二级参考文献147

共引文献59

同被引文献50

  • 1周江,丁彦.冠心病治疗方法的比较思考[J].医学与哲学(B),2006,27(4):36-39. 被引量:5
  • 2刘振江,周胜华,沈向前.替罗非班对急性ST段抬高型心肌梗死患者介入治疗术后心肌组织灌注水平的影响[J].临床心血管病杂志,2007,23(6):417-420. 被引量:8
  • 3Saltzman AJ,Mehran R, Hooper WC,et al. The relative effects of ab-ciximab and tirofiban on platelet inhibition and C -reactive proteinduring coronary intervention [J]. J Invasive Cardiol, 2010,22 : 2-6.
  • 4Thiele H,Schindler K,Friedenberger J,et al. Intracoronary comparedwith intravenous bolus abciximab application in patients with ST-el-evation myocardial infarction undergoing primary percutaneous coro-nary intervention : the randomized Leipzig immediate percutaneouscoronary Intervention abciximab IV versus IC in ST -elevation my-ocardial infarction trial [J]. Circulation, 2008,18: 49-57.
  • 5Bovill EG,Terrin Ml,Stump Dc,et al. Hemorrhagic events duringtherpy with recomibinant tissue -ype plasminogen activator heparinand aspirin for acute myocardial infarction. Result of the thrombojysisin myocardial infarction (TIMI)Phase II trial [J]. Ann Inter Med,1991,1154.-256-265.
  • 6Napodano M,Ramondo A,Tarantini G. Predictors and time -relatedimpact of distal embolization during primary angioplasty [J]. EurHeart J,2009,30:305-313.
  • 7Fokkema ML, Vleuten PA. Incidence, predictors, and outcome of rein-farction and stent thrombosis within one year after primary percuta-neous coronary intervention for ST-elevation mvocaTdiai infarction [J].Catheter Cardiovasc Interv,2009,73:627-634.
  • 8Okamura A,Ito H, Iwakura K,et al. Clinical implications of distalembolization during coronary interventional procedures in patientswith acute myocardial infarction : quantitative study with Dopplerguidewire [J]. JACC Cardiovasc Inter V, 2008,1 : 268-276.
  • 9De Luca G,Ucci G,Cassetti E,et al. Benefits from small moleculeadministration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angio-plasty : a meta-analysis [J]. J Am Coll Cardiol ,2009,53 : 1668-1673.
  • 10Thiele H,Wohrle J.Neuhaus P,et al. Intracoronary compared withintravenous bolus abciximab application during primary percuta-neous coronary intervention ; design and rationale of the AbciximabIntracoronary Versus Intravenously Drug Application in ST-Eleva-tion Mvocardial Infarction (AIDA STEMI)trial [J]. Am Heart J,2010,159:547-554.

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部